Efficacy of Low-dose Vonoprazan for Helicobacter Pylori Eradication

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The primary objective of this retrospective study was to assess the efficacy and safety of a bismuth quadruple regimen of a low-dose potassium-competitive acid blocker versus a standard-dose potassium-competitive acid blocker and a standard-dose proton pump inhibitor combined with amoxicillin and clarithromycin as the initial treatment of Helicobacter pylori infection.
Epistemonikos ID: 40001f77b8153e198a300aeb84ebc83c35917499
First added on: May 15, 2024